What does Drs. Pinxten-Noben do?

Drs. Pinxten-Noben is a specialist medical practice in Diepenbeek. Private Limited, started on 22 January 2001, 1 establishment.

What is the address of Drs. Pinxten-Noben?

The registered office of Drs. Pinxten-Noben is located at Stationsstraat 88, 3590 Diepenbeek.

Is Drs. Pinxten-Noben still active?

Yes. According to the CBE (30 October 2026) Drs. Pinxten-Noben is active, legal situation “Normale toestand”, started on 22 January 2001.

Is Drs. Pinxten-Noben registered on Peppol?

Yes, Drs. Pinxten-Noben is registered on the Peppol network with ID 0208:0473765519.

What is the enterprise number of Drs. Pinxten-Noben?

The enterprise number of Drs. Pinxten-Noben is BE0473765519.

When was Drs. Pinxten-Noben founded?

Drs. Pinxten-Noben was founded on 22 January 2001.

Who are the directors of Drs. Pinxten-Noben?

According to the 2025 annual accounts, the directors of Drs. Pinxten-Noben are: Kathelijne Noben, Erik Pinxten.

Is Drs. Pinxten-Noben a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 January 2001; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Drs. Pinxten-Noben make in 2025?

Drs. Pinxten-Noben posted a profit after taxes of € 425,506 in financial year 2025.

What is the revenue of Drs. Pinxten-Noben?

As a small company, Drs. Pinxten-Noben is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 807,928.

How much does an employee at Drs. Pinxten-Noben earn?

The average wage cost per full-time employee at Drs. Pinxten-Noben was € 71,000 in 2025: staff costs of € 177,604 for 2.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Drs. Pinxten-Noben have?

According to the 2025 annual accounts, Drs. Pinxten-Noben has 2.5 full-time equivalents (FTE).

Drs. Pinxten-Noben (Private Limited) - Diepenbeek

Dossier Drs. Pinxten-Noben, printed on 30 October 2026 from databakkes.be/en/0473765519/drs-pinxten-noben. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Shrinking team NBB

FTE fell two years in a row, from 3.1 to 2.5.

Financials

Financial year 2025

Drs. Pinxten-Noben from Diepenbeek, company number BE0473765519, closed financial year 2025 with a result of € 425,506 after tax. For that financial year Drs. Pinxten-Noben recorded a gross margin of € 807,928 and equity of € 3.3 million. Compared with financial year 2024, the result moved from € 421,699 to € 425,506. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.

What it is worth Growing

€ 3.3 million

▲ 14% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 425,506

▲ 1% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 432,500

▲ € 333,380 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 1,666 paid out

0 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

2.5

▼ 0.5 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 177,604

▼ 5% vs 2024

€ 71,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 91,256

▼ 25% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 130,233

▼ 36% vs 2024

€ 47,301 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 19,005

▲ 29% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 89,755

▲ 79% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 652,185 Gross margin 2022: € 652,185 First fiscal year in the series	€ 700,430 Gross margin 2023: € 700,430 ▲ 7% vs 2022 (€ 652,185) Favourable step	€ 770,552 Gross margin 2024: € 770,552 ▲ 10% vs 2023 (€ 700,430) Favourable step	€ 807,928 Gross margin 2025: € 807,928 ▲ 5% vs 2024 (€ 770,552) Favourable step	▲ 5%
Profit after taxes	€ 311,093 Profit after taxes 2022: € 311,093 First fiscal year in the series	€ 307,657 Profit after taxes 2023: € 307,657 ▼ 1% vs 2022 (€ 311,093) Unfavourable step	€ 421,699 Profit after taxes 2024: € 421,699 ▲ 37% vs 2023 (€ 307,657) Favourable step	€ 425,506 Profit after taxes 2025: € 425,506 ▲ 1% vs 2024 (€ 421,699) Favourable step	▲ 1%
Equity	€ 2,178,618 Equity 2022: € 2,178,618 First fiscal year in the series	€ 2,474,525 Equity 2023: € 2,474,525 ▲ 14% vs 2022 (€ 2,178,618) Favourable step	€ 2,884,407 Equity 2024: € 2,884,407 ▲ 17% vs 2023 (€ 2,474,525) Favourable step	€ 3,298,097 Equity 2025: € 3,298,097 ▲ 14% vs 2024 (€ 2,884,407) Favourable step	▲ 14%
Total debts	€ 344,063 Total debts 2022: € 344,063 First fiscal year in the series	€ 301,873 Total debts 2023: € 301,873 ▼ 12% vs 2022 (€ 344,063) Favourable step	€ 289,391 Total debts 2024: € 289,391 ▼ 4% vs 2023 (€ 301,873) Favourable step	€ 262,741 Total debts 2025: € 262,741 ▼ 9% vs 2024 (€ 289,391) Favourable step	▼ 9%
Cash	€ 91,022 Cash 2022: € 91,022 First fiscal year in the series	€ 376,986 Cash 2023: € 376,986 ▲ € 285,965 vs 2022 (€ 91,022) Favourable step	€ 99,120 Cash 2024: € 99,120 ▼ 74% vs 2023 (€ 376,986) Unfavourable step	€ 432,500 Cash 2025: € 432,500 ▲ € 333,380 vs 2024 (€ 99,120) Favourable step	▲ € 333,380
Land & buildings	€ 245,521 Land & buildings 2022: € 245,521 First fiscal year in the series	€ 240,316 Land & buildings 2023: € 240,316 ▼ 2% vs 2022 (€ 245,521) Unchanged	€ 265,747 Land & buildings 2024: € 265,747 ▲ 11% vs 2023 (€ 240,316) Unchanged	€ 250,071 Land & buildings 2025: € 250,071 ▼ 6% vs 2024 (€ 265,747) Unchanged	▼ 6%
Retained profit	€ 2,072,418 Retained profit 2022: € 2,072,418 First fiscal year in the series	€ 2,368,325 Retained profit 2023: € 2,368,325 ▲ 14% vs 2022 (€ 2,072,418) Favourable step	€ 2,778,207 Retained profit 2024: € 2,778,207 ▲ 17% vs 2023 (€ 2,368,325) Favourable step	€ 3,191,897 Retained profit 2025: € 3,191,897 ▲ 15% vs 2024 (€ 2,778,207) Favourable step	▲ 15%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 1,600 Dividend 2023: € 1,600 Unchanged (€ 0) Unchanged	€ 1,666 Dividend 2024: € 1,666 ▲ 4% vs 2023 (€ 1,600) Unchanged	€ 1,666 Dividend 2025: € 1,666 Unchanged (€ 1,666) Unchanged
Bank debt	€ 106,253 Bank debt 2022: € 106,253 First fiscal year in the series	€ 249,392 Bank debt 2023: € 249,392 ▲ 135% vs 2022 (€ 106,253) Unfavourable step	€ 202,386 Bank debt 2024: € 202,386 ▼ 19% vs 2023 (€ 249,392) Favourable step	€ 130,233 Bank debt 2025: € 130,233 ▼ 36% vs 2024 (€ 202,386) Favourable step	▼ 36%
Balance sheet total	€ 2,522,681 Balance sheet total 2022: € 2,522,681 First fiscal year in the series	€ 2,776,398 Balance sheet total 2023: € 2,776,398 ▲ 10% vs 2022 (€ 2,522,681) Unchanged	€ 3,173,798 Balance sheet total 2024: € 3,173,798 ▲ 14% vs 2023 (€ 2,776,398) Unchanged	€ 3,560,838 Balance sheet total 2025: € 3,560,838 ▲ 12% vs 2024 (€ 3,173,798) Unchanged	▲ 12%
Employees (FTE)	3.1 Employees (FTE) 2022: 3.1 First fiscal year in the series	3.1 Employees (FTE) 2023: 3.1 Unchanged (3.1) Unchanged	3 Employees (FTE) 2024: 3 ▼ 0.1 vs 2023 (3.1) Unchanged	2.5 Employees (FTE) 2025: 2.5 ▼ 0.5 vs 2024 (3) Unchanged	▼ 0.5

Key figures of Drs. Pinxten-Noben, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Drs. Pinxten-Noben?

What happened at Drs. Pinxten-Noben in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2030 Kathelijne Noben stepped down as director. NBB
2030 Erik Pinxten stepped down as director. NBB
Sep 30, 2026 New annual accounts for financial year 2025: profit of € 425,506 (▲ 1% vs 2024). filed late Source: NBB ↗
Jun 4, 2007 New establishment in Diepenbeek. KBO
2005 Kathelijne Noben became a director. NBB
Jan 22, 2001 Start of the company according to the CBE. KBO
2001 Erik Pinxten became a director. NBB

In short

From € 311,093 profit in 2022 to € 425,506 profit in 2025.

Paid € 681,251 in corporate taxes since 2022.

Best year ever: 2025, with € 425,506 profit.

On average € 323,200 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Drs. Pinxten-Noben

Pinopa 94.4%

It owns 94.4% of Pinopa itself.

Directors

According to the 2025 annual accounts

Kathelijne Noben

Director

since 2005 · until 2030

Erik Pinxten

Director

Also active at: Pinopa, DEMERHUIS

since 2001 · until 2030

Establishments

Establishment units

Physical locations of this company

Registered office

Stationsstraat 88

3590 Diepenbeek

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Pinopa same network

€ 53,960 gross margin · 2025

Oogartsen Odeo

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0473.765.519

VAT number

BE 0473.765.519

Registered office

Stationsstraat 88, 3590 Diepenbeek

Names & denominations

Drs. Pinxten-Noben

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

22 January 2001

Peppol

Active · Active since 23 Jan 2026

Activities · NACE

Activiteiten van medisch specialisten

Activiteiten van medische beeldvorming en medische laboratoria

Activiteiten van medische laboratoria

View on CBE Public ↗ Annual accounts (NBB) ↗

Drs. Pinxten-Noben

Warning lights

Financials

What happened to Drs. Pinxten-Noben?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions